Creative Biolabs is looking for potential partners (include but not limit to major pharma or biotech firms) to develop LAG-3 therapeutic monoclonal antibody program together. Our scientists are dedicated to bringing years of valuable experience to our partner and achieve a meaningful partnership together. For any partners interested in our Next-IO™ programs, Creative Biolabs welcomes collaboration.
Learn more about Next-IO™ Anti-LAG-3 Therapeutic Monoclonal Antibody Program: https://www.creative-biolabs.com/immuno-oncology/anti-lag-3-therapeutic-monoclonal-antibody-program.htm

#Health#biotech